Contents

Funded vaccines for special groups

See the Pharmaceutical Schedule (www.pharmac.govt.nz) for the number of funded doses and any changes to the funding decisions.

Vaccine Individuals eligible for funded vaccine
Hep A Transplant patients. Children with chronic liver disease. Close contacts of hepatitis A cases.
Hep B and HBIG Hep B and HBIG at birth for babies of mothers with chronic hepatitis B infection. Hep B vaccine for: household or sexual contacts of HBsAg-positive patients; children <18 years who have not achieved positive serology and who require additional vaccination; HIV- or hepatitis C-positive patients; following non-consensual sexual intercourse; following immunosuppression; transplant or dialysis patients; following needle-stick injury.
Hib Post- HSCT or chemotherapy; pre- or post-splenectomy or with functional asplenia; pre- or post-solid organ transplant, pre- or post-cochlear implants, renal dialysis and other severely immunosuppressive regimens.
HPV Individuals aged 9–26 years: with confirmed HIV infection; transplant (including stem cell) patients; an additional dose post-chemotherapy.
Influenza Individuals ≥65 years. Patients aged 6 months to <65 years with certain medical conditions. Pregnant women. 
MMR For (re-)vaccination following immunosuppression.
MenCCV and MCV4-D Pre- or post-splenectomy or with functional asplenia; with HIV, complement deficiency (acquired or inherited) or pre- or post-solid organ transplant; close contacts of meningococcal cases; bone marrow transplant patients; following immunosuppression.
Pertussis-containing vaccine Tdap for pregnant women, from 28 to 38 weeks’ gestation. Tdap, DTaP-IPV-HepB/Hib or DTaP-IPV for (re-)vaccination: post-HSCT or chemotherapy; pre- or post-splenectomy; pre- or post-solid organ transplant, renal dialysis and other severely immunosuppressive regimens.
PCV13 and 23PPV HIV infection; post HSCT or chemotherapy; pre- or post-splenectomy or with functional asplenia; pre- or post-solid organ transplant; renal dialysis; with complement deficiency (acquired or inherited); with cochlear implants; with primary immune deficiency.
IPV For (re-)vaccination following immunosuppression.
Td For (re-)vaccination following immunosuppression.
BCG Infants and children <5 years at increased risk of TB.
Varicella Non-immune patients: with chronic liver disease who may need a transplant in the future; with deteriorating renal function before transplant; prior to solid organ transplant; prior to elective immunosuppression; for post-exposure prophylaxis of immune competent in-patients. Patients at least 2 years after bone marrow transplant or at least 6 months after completion of chemotherapy, on advice of their specialist. HIV-positive patients with mild or moderate immunosuppression who are non-immune to varicella, on advice of their specialist. Patients with inborn errors of metabolism at risk of major metabolic decompensation, with no clinical history of varicella. Household contacts of paediatric patients who are immune compromised, or undergoing a procedure leading to immune compromise, where the household contact has no clinical history of varicella. Household contacts of adult patients who have no clinical history of varicella and who are severely immune compromised or undergoing a procedure leading to immune compromise, where the household contact has no clinical history of varicella.